Literature DB >> 25288787

Successful treatment of warm-type haemolytic anaemia with bortezomib in a rituximab-failed systemic lupus erythematosus patient.

Yu Wang1, Wei Zhou1, Zhuoli Zhang2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25288787     DOI： 10.1093/rheumatology/keu393

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  3 in total

1.  Bortezomib-based antibody depletion for refractory autoimmune hematological diseases.

Authors:  Sumita Ratnasingam; Patricia A Walker; Huy Tran; Zane S Kaplan; James D McFadyen; Huyen Tran; Tse-Chieh Teh; Shaun Fleming; John V Catalano; Sanjeev D Chunilal; Anna Johnston; Stephen S Opat; Jake Shortt
Journal:  Blood Adv       Date:  2016-11-22

Review 2.  Key issues in the management of patients with systemic lupus erythematosus: latest developments and clinical implications.

Authors:  Natasha Jordan; David D'Cruz
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-12       Impact factor: 5.346

3.  Combination of low-dose rituximab, bortezomib and dexamethasone for the treatment of autoimmune hemolytic anemia.

Authors:  Mingkang Yao; Jingjing Zhang; Ying Li; Linlin Lv; Lu Jia; Chunyan Yang; Yu Huang; Haihui Liu; Jian Wang; Mingtai Chen; Hao Zhang
Journal:  Medicine (Baltimore)       Date:  2022-01-28       Impact factor: 1.889
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.